トップへ戻る

※Package design is subject to change without notice.

  • Code:005340-002
  • Tsumura Juumihaidokuto[6] : 42 sachets(for two weeks)
  • $36.49

Up to 4 pieces per person

10% discount for total amount over $100

shipping schedule : about 3 weeks after payment

warehouse:Japan1

Manufacturer :TSUMURA & CO.

Brand :TSUMURA & CO.

JAN Code:4987138800695

  • Description
      Jumihaidokuto is indicated for the relief of the followingsymptoms:Symptoms in the early stage of suppurative dermatosis or acute dermatosis, urticaria, acute eczema, and tinea pedis
  • Active Ingredients
      7.5 g(3sachets for 1day) of TSUMURA Jumihaidokuto extract granules contains 3.5 g of a dried extract of the following mixed crude drugs.JP Platycodon Root 3.0 gJP Bupleurum Root 3.0 gJP Cnidium Rhizome 3.0 gJP Poria Sclerotium 3.0 gJP Quercus Bark 3.0 gJP Aralia Rhizome 1.5 gJP Saposhnikovia Root 1.5 gJP Glycyrrhiza 1.0 gJP Schizonepeta Spike 1.0 gJP Ginger 1.0 g(JP: The Japanese Pharmacopoeia)
  • Effect/Efficacy
      Seborrheic dermatitis and dandruff
      Pyoderma, folloculitis, furunculosis
      Atopic dermatitis, eczema
      Urticaria
      Pulmoplantar pustolosis
      Rosacea
      Acne
  • Usage/Dosage
      The usual adult dose is 7.5 g/day orally in 2 or 3 divided doses before or between meals. The dosage may be アadjusted according to the patient's age and body weight and symptoms.
  • Cautions
      Careful administration(TJ-6should be administered with care in the following patients.)
      (1) Patients with greatly declined constitution [The skin manifestation may be aggravated.]
      (2) Patients with an extremely weak gastrointestinal tract [Anorexia, epigastric distress, nausea, diarrhea, etc. may occur.]
      (3) Patients with anorexia, nausea or vomiting [These symptom may be aggravated.]

      Important Precautions
      (1)When TJ-6 is used, the patient’s “SHO” (constitution/symptoms) should be taken into account. The patient’s progress should be carefully monitored, and if no improvement in symptoms/findings is observed, continuous treatment should be avoided.
      (2) Since TJ-6 contains Glycyrrhiza, careful attention should be paid to the serum potassium level, blood pressure, etc., and if any abnormality is observed, ad ministration should be discontinued.
      (3) When TJ-6 is co-administered with other Kampo-preparations (Japanese traditional herbal medicines), etc., attention should be paid to the duplication of the contained crude drugs.

      SHO: The term “SHO” refers to a particular pathological status of a patient evaluated by the Kampo diagnosis, and is patterned according to the patient’s constitution, symptoms, etc. Kampo-preparations (Japanese traditional herbal medicines) should be used after confirmation that it is suitable for the identified “SHO” of the patient.
  • Contraindication
      TJ-6 has not been investigated (drug use investigations, etc.) to determine the incidence of adverse reactions. Therefore, the incidence of adverse reactions is not known.

      (1) Clinically significant adverse reactions
      1) Pseudoaldosteronism: Pseudoaldosteronism such as hypokalemia, increased blood pressure, retention of sodium/body fluid, edema, increased body weight, etc. may occur. The patient should be carefully monitored (measurement of serum potassium level, etc.), and if any abnormality is observed, administration should be discontinued and appropriate measures such as administration of potassium preparations should be taken.
      2) Myopathy: Myopathy may occur as a result of hypokalemia. The patient should be carefully monitored, and if any abnormality such as weakness,convulsion/paralysis of limbs, etc. are observed, administration should be discontinued and appropriate measures such as administration of potassium preparations should be taken.

      (2) Other adverse reactions
      Hypersensitivity-Rash, redness, Pruritus, Ulticaria, etc.
      Gastrointestinal Anorexia, Epigastric distress, Nausea, Diarrhea, etc.

      Note 1) If such symptoms are observed, administration should
Now Loading...

Now Loading...